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There is a growing body of evidence supporting the immunomodulation effects of testosterone. Previous researches 
have focused on its direct blunt inflammatory effect on mediation of cytokines secretion through down-regulated 
expression of toll-like receptor 4 (TLR4). However, how testosterone modulates immune responses via mechanisms 
of TLR4 downstream molecules has not yet been elucidated. Recently, we have firstly confirmed that testosterone 
deficiency is the main reason that caused the exacerbate inflammation status in rat spleen. Orchidectomy in rats 
resulted in a markedly enhance of spleen weight (splenomegaly) and basal production of nitric oxide (NO) from 
splenocytes. Moreover, lipopolysaccharide (LPS) amplified proliferation rate of splenocytes and the production of 
tumor necrosis factor-alpha (TNF-α) following castration. Extracellular signal-regulated kinase (ERK) is a critical 
mediator of TLR4 cascades, and we further examined whether absence of endogenous testosterone affects ERK 
expression. As anticipated, orchidectomized rats manifested an increased phosphorylation of ERK. Furthermore, 
testosterone administration was demonstrated to be associated with a diminished LPS-evoked TNF-α and NO 
secretion in a dose-dependent manner. In the present study, we answered how testosterone withdrawal affects 
downstream signaling cascades of TLR4 and supports that testosterone might potentially ameliorate inflammatory 
responses. Our findings mention the possibility that testosterone functions might serve as a useful endogenous 
regulator of immune responses. 
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Testosterone is a gonadal steroid hormone synthesized and 
released by the Leydig cells of the testes [1]. Traditionally,  
testosterone is believed to be only involved in reproductive 
function. However, in the last two decades, several clinical and 
experimental studies have highlighted the significance 
relationship between testosterone and immune-related 
diseases [2-4]. For instance, testosterone supplementation 
reverses clinical status and inflammatory parameters in 
humans with rheumatoid arthritis and systemic lupus 
erythematosus or mice with anemia [2-5]. Moreover, low 
concentrations of testosterone were associated with increased 
expression of inflammatory biomarkers. Emerging studies 
have revealed that testosterone levels are inversely correlated 
with a number of inflammatory mediators, e.g. C-reactive 
protein, interleukin-1β, tumor necrosis factor-α (TNF-α), and 
interleukin-6 (IL-6) [6-9] in humans. Further research studies 
also confirmed these results in animal or cell models [10-13]. In 
other words, testosterone may abrogate inflammatory 
cytokines [10-13] and elevates anti-inflammatory cytokines 
secretion [14]. Taken together, these experimental studies 
suggested that testosterone has potential advantageous effects 
on immune system. Although, many studies aimed to 
demonstrate the causality of relationship between testosterone 
and anti-inflammatory response, how testosterone regulates 
actual mechanism of immune responses has not yet been 
elucidated. This is an important issue for anti-inflammation 
effect of testosterone. 
 
Toll-like receptor 4 (TLR4) plays a critical role in 
modulating and initiating inflammatory responses [10, 11]. 
TLR4 located on the surface of immune cells and has been 
shown to bind gram-negative bacteria lipopolysaccharide 
(LPS). The activation of TLR4 triggers downstream 
intracellular signaling cascades, including extracellular signal-
regulated kinase (ERK), c-Jun-N-terminal kinase (JNK), and 
the p38 subfamilies leading to secretion of inflammatory 
molecules [15, 16]. Hence, block of TLR4 activity can prevent 
excessive inflammation and consequent development of 
immune-related diseases. The concept of testosterone 
regulating TLR4 have been first suggested by Rettew who 
demonstrated that testosterone withdrawal increases 
inflammation as assessed by TNF-α and IL-6 concentrations 
after high expression of TLR4 on macrophage in 
orchidectomized mouse [10]. In addition, castrated mice 
severity (moribund) scores were higher than normal mice after 
endotoxic shock assessment [10]. This was the first study that 
purposed to examine the inflammatory signaling on immune 
cell in the presence or absence of testosterone. Subsequent 
researches have verified this finding. Leimgruber et al. 
described that the absence of testosterone can not only enlarge 
LPS-stimulated TLR4 and phospho-ERK expressions but also 
promote TNF-α and IL-6 productions in prostate smooth 
muscle cells, the non-professional immune cells via 
nuclear factor-kappa B translocation [11]. However, it is not 
entirely clear how fluctuations in TLR4 cascade are associated 
with testosterone deficiency in the specific immune cells. 
 
Spleen is a secondary lymphoid organ that plays a major 
role in innate and adaptive immunity [17]. The spleen can 
defense against multiple antigens in the circulation, and is an 
efficient site of antibody production [18, 19]. Splenocytes consist 
of various immune cells, including B cells, T cells, monocytes 
which possess the ability to mediate  inflammatory diseases, 
such as rheumatoid arthritis [20] and autoimmune thyroiditis [21]. 
On the other hand, previous studies have reported that LPS 
could stimulate the proliferation of splenocytes [22, 23]. 
Additionally, splenocytes proliferation plays a crucial role in 
the cascade activation of cellular inflammatory responses [11, 
22, 23]. As aforementioned, LPS-challenged immune responses 
of splenocytes can mimic the inflammation conditions. Hence, 
this model is commonly applied to investigate many 
inflammatory-related studies. Based on previous work 
illustrating that testosterone is able to exert immune 
suppression effects [10-12], we speculated that removing 
endogenous testosterone would deteriorate inflammatory 
responses. In the present study, after 2-week orchidectomy, 
castrated rats markedly promote LPS-evoked TNF-α and cell 
proliferation in splenocytes as compared with intact rats [13]. 
However, testosterone propionate supplement restored these 
phenomenon in castrated rats [13]. In addition,  it has been 
widely accepted that splenomegaly arises as a consequence of 
inflammation [24, 25]. In our study, spleen morphology analyses 
revealed that significant elevation of spleen weight and spleen 
weight/body weight ratio in orchidectomized rats, but this 
result disappeared in the testosterone   propionate-
administered   orchidectomized rats 
[13]
. These findings support the hypothesis that testosterone 
might have a potential benefit to modulate the immune system. 
We have illustrated current study of our main findings in the 
Figure 1. 
 
Detailed molecular mechanism of how testosterone 
fluctuates TLR4 cascade proteins is not fully clear which 
warrants further probe into the role of potential signaling. 
Specifically, ERK serves as an important and crucial signal 
effector from TLR4 downstream. Accumulating evidence 
indicated that down-regulation of ERK was might obstruct 
secretion of inflammatory molecules secretion [26-28]. In our 
recent research, we examined the ERK activated by 
testosterone withdrawal in spleen and subsequently showed 
that ERK phosphorylation was enhanced about 2-fold in the 
absence of endogenous testosterone of rats [13]. In addition, the 
present data demonstrated that testosterone deficiency 
significantly reinforces effects of secretion on LPS-induced 
TNF-α secretion, which could explain the ERK activation 
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Figure 1. Proposed endogenous testosterone withdrawal that resulted in considerable immunological changes in 
the rat spleen. The rats underwent bilateral orchidectomy for two weeks, and the following immune adaptations were shown 
in spleen: (i) splenomegaly, (ii) enhanced phosphorylation of extracellular signal-regulated kinase (ERK) that was 
downstream signaling molecules of toll-like receptor 4 (TLR4), (iii) increased basal nitric oxide (NO) and lipopolysaccharide 
(LPS)-evoked tumor necrosis factor-alpha (TNF-α) secretion in splenocytes. 
 
signaling on consequence of inflammatory response in 
orchidectomized rats [13]. However, testosterone propionate 
replacement restored the above results in castrated rats [13]. In 
this context, we have shown for the first time that removal of 
endogenous testosterone promotes the inflammatory 
mediators secretion via ERK signal activation. Further, we 
have clarified and confirmed in the present study that 
testosterone significantly diminished the inflammatory 
responses. We found that testosterone suppressed LPS-
stimulated TNF-α and nitric oxide production in a dose-
dependent manner without any specific undesirable 
cytotoxicity in splenocytes [13]. These effects of testosterone 
seem to be advantageous to anti-inflammation, and indeed, a 
number of studies have reported that testosterone is associated 
with attenuation of cytokines in professional or non-
professional immune cells [10-13]. 
 
In summary, the results of our study provide scientific 
evidence that endogenous testosterone might display 
anti-inflammatory activity via dampening the phospho-ERK 
expression. The current study extends our knowledge of the 
signaling mechanisms underlying testosterone exerts immune 
suppression effects. Additionally, testosterone can potentially 
inhibit LPS-evoked inflammatory molecules. Thus, this work 
might support the use of testosterone as a prescription for the 
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